Vandetanib, sold under the brand name Caprelsa, is an anti-cancer medication that is used for the treatment of certain tumours of the thyroid gland. It...
14 KB (1,191 words) - 04:16, 26 September 2024
Österreichischer Apothekerverlag. Sedacoron 200 mg-Tabletten. "Caprelsa (vandetanib) Tablets, for Oral Use. Full Prescribing Information" (PDF). Sanofi Genzyme...
23 KB (2,510 words) - 05:34, 5 August 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
10 KB (579 words) - 06:46, 26 June 2024
abnormalities, and thrombotic or bleeding episodes.[citation needed] Vandetanib, trade name Caprelsa, was the first drug (April 2011) to be approved by...
19 KB (2,285 words) - 13:12, 25 August 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
13 KB (1,177 words) - 02:19, 4 September 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
27 KB (3,078 words) - 18:33, 22 September 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
25 KB (2,086 words) - 02:24, 16 July 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
34 KB (3,021 words) - 12:39, 5 August 2024
Digestive and Kidney Diseases, 2012, PMID 31643478, retrieved 2024-04-11 "Vandetanib dosing, indications, interactions, adverse effects, and more". Medscape...
52 KB (708 words) - 12:37, 26 August 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
68 KB (5,999 words) - 20:41, 31 August 2024